Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Becton Dickinson Stories

2013-10-28 12:25:10

Initiative Seeks to Expand Access and Improve Healthcare for Underserved and Vulnerable Populations in the U.S. Through Support to Clinics and Community Health Centers FRANKLIN LAKES, N.J., Oct. 28, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, together with Direct Relief and the National Association of Community Health Centers (NACHC), today launched BD Helping Build Healthy Communities(SM), a four-year...

2013-10-25 08:26:28

BERWYN, Pa., Oct. 25, 2013 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced the appointment of James O. Davis as Vice President and General Manager of AMETEK's Process & Analytical Instruments (P&AI) Division. "I am pleased that Jim has joined AMETEK. He has extensive general management experience, especially in process control and measurement instrumentation, and we expect him to play a key role in the continued success of our process and analytical instruments...

2013-10-16 04:21:44

Expansion of Product Portfolio for Microbiological Analyses in the Lab GOETTINGEN, Germany and BALTIMORE, Oct. 16, 2013 /PRNewswire/ -- Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, and BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration to develop, manufacture and market various ready-to-use, prefilled media products for microbiological...

2013-09-30 23:26:29

Reportbuyer.com just published a new market research report: Needle-Free Delivery: Technology And Market 2013-2023. (PRWEB) September 30, 2013 Report Details Needle-free delivery - discover technological and commercial prospects What does the future hold for the needle-free delivery market? Visiongain's report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for the overall needle-free injection technology market. There is urgent need for...

2013-09-27 16:23:59

FRANKLIN LAKES, N.J., Sept. 27, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2013 earnings conference call on Tuesday, November 5, 2013, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at...

2013-09-27 08:25:58

Innovative collaboration with Saving Lives at Birth partners to develop the Odon Device for assisted delivery of newborns FRANKLIN LAKES, N.J., Sept. 27, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and the World Health Organization (WHO), together with Saving Lives at Birth: A Grand Challenge for Development partners, today announced a commitment to develop and launch the Odon Device, an innovative new obstetrical...

2013-09-20 08:25:18

FRANKLIN LAKES, N.J., Sept. 20, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that a jury has returned a mixed verdict in the lawsuit filed against the Company by Retractable Technologies, Inc. (RTI) in the United States Court for the Eastern District of Texas. The verdict was unfavorable to BD with respect to RTI's Lanham Act claim and claim for attempted monopolization based on deception in the safety syringe market. The jury has awarded RTI...

2013-09-05 12:27:30

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) research report by Kalorama Information is now available through RnRMarketResearch.com. DALLAS, Sept. 5, 2013 /PRNewswire-iReach/ -- This report focuses on preventing, testing and treating hospital-acquired infections in the healthcare environment. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in...

2013-09-05 08:29:05

NanoString Technologies and BD Biosciences Sign Collaboration Agreement to Develop Single Cell Isolation and Analysis Workflow SEATTLE and SAN JOSE, Calif., Sept. 5, 2013 /PRNewswire/ -- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, and BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration...

2013-08-30 08:24:39

FRANKLIN LAKES, N.J., Aug. 30, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in September 2013: 2013 Morgan Stanley Global Healthcare ConferenceMonday, September 9, 20131:50 p.m. ET Stifel Nicolaus 2013 Healthcare ConferenceWednesday, September 11, 20131:30 p.m. ET Live webcasts of BD's presentations can be accessed on the BD...